3,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridazine, 97%, 25g

2-((tert-Butoxycarbonyl)amino)-2-(2,4-difluorophenyl)acetic acid, 98%, 5g

8-Bromo-2,4-dichloroquinoline, 95.0%, 5g

3-(1-Methyl-1H-pyrazol-3-yl)-benzenesulfonamide, 95.0%, 1g

TRANS-TERT-BUTYL 4-HYDROXY-3-PHENYLPIPERIDINE-1-CARBOXYLATE, 95.0%, 250mg

Ethyl 1-(3-chlorophenyl)-5-trifluoromethyl-1H-pyrazole-4-carboxylate, 97.0%, 1g

(2E)-1-(2-methoxyphenyl)-3-(4-methylphenyl)prop-2-en-1-one, 95.0%, 10g

Ethyl 7-chloropyrazolo[1,5-a]pyrimidine-6-carboxylate, 95.0%, 5g

6-Bromo-2-cyclopropyl-5-methylbenzo[d]oxazole, 98%, 250mg

(2-Iodo-3-methoxyphenyl)methanol, 97+%, 1g

Sodium chloride solution, ROTI®Volum 0.1 mol/l - 0.1 N, ampoule, 1 piece, plastic packaging.

(4-Methyl-2-phenylpyrimidin-5-yl)methanol, 95.0%, 100mg

2-[(4-methoxyphenyl)methyl]oxirane, 95.0%, 250mg